Achieve Life Sciences Reports 52-Week Safety Data for Cytisinicline
SEATTLE and VANCOUVER, British Columbia, May 19, 2026 Achieve Life Sciences announced positive long-term safety data from the ORCA-OL...
Respiratory Medicine
Advertisement
Oorja Bio Reports Positive Phase 1 Data for ORJ-001 in IPF
HOUSTON, Texas, May 19, 2026 Oorja Bio announced positive first-in-human Phase 1 clinical data for ORJ-001, a first-in-class peptide...
AstraZeneca’s FASENRA Wins FDA Approval for HES
WILMINGTON, Del., May 14, 2026 AstraZeneca announced that the U.S. Food and Drug Administration has approved FASENRA® (benralizumab) for...
GSK Wins China Approval for Exdensur in Severe Asthma
LONDON, UK — March 30, 2026 In a major advancement in respiratory medicine and biologic drug innovation, GSK plc...
Ritedose Expands U.S. Nebulized Drug Portfolio with FDA Approval
COLUMBIA, S.C., October 30, 2025 — The Ritedose Corporation has received U.S. Food and Drug Administration (FDA) approval to...
Advertisement
